WELL Health Technologies Corp (WELL) — Capital Reinvestment Ratio

Latest as of September 2025: 0.26x

WELL Health Technologies Corp (WELL) has a Capital Reinvestment Ratio of 0.26x as of September 2025, meaning it reinvests 0% of its operating cash flow (CA$75.84 Million) in capital expenditures (CA$19.39 Million). Check WELL tangible net worth ratio to evaluate the tangible quality of the company's equity base.

Capital Reinvestment Ratio

0.26x
Capex / Operating Cash Flow

Operating Cash Flow

CA$75.84 Million
CAD

Capital Expenditures

CA$19.39 Million
CAD

Data as of

Sep 2025
Most recent filing

WELL Health Technologies Corp Capital Reinvestment Ratio (2021–2024)

This chart tracks WELL Health Technologies Corp's Capital Reinvestment Ratio across 4 annual periods. For the full cash flow conversion analysis, see WELL cash flow metrics.

Annual Capital Reinvestment Ratio for WELL Health Technologies Corp (2021–2024)

Year-by-year Capital Reinvestment Ratio for WELL Health Technologies Corp from 2021 to 2024. See free cash flow generation of WELL Health Technologies Corp to measure how efficiently the company converts operating cash flow to free cash.

Year Reinvestment Ratio Operating CF (CAD) Capital Expenditures YoY Change
2024 1.70x CA$9.52 Million CA$16.23 Million ▲ +346.0%
2023 0.38x CA$66.44 Million CA$25.38 Million ▲ +356.7%
2022 0.08x CA$76.55 Million CA$6.40 Million ▼ -30.5%
2021 0.12x CA$22.27 Million CA$2.68 Million
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow